We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HKLB:LSEHongkong Land Holdings Limited Analysis

Data as of 2026-06-21 - not real-time

$7.41

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Hongkong Land is trading at a flat 7.41 USD, exactly on its 20‑day, 50‑day and 200‑day simple moving averages, while the 14‑day RSI is at a full 100, signalling a severely overbought condition. Technical indicators therefore point to a short‑term pull‑back despite a neutral MACD, and the model flags a bearish trend direction. Fundamentally, the company is under pressure: revenue has fallen 32% YoY, trailing EPS is negative (-0.15), free cash flow is deeply negative (‑1.74 bn USD) and debt‑to‑equity is extremely high at 19.9, indicating a leveraged balance sheet. The price‑to‑book ratio of 0.52 suggests the stock is cheap relative to its net asset value, but the lack of dividend and zero analyst coverage add to uncertainty.
In the medium to long term the asset base in prime Hong Kong, Singapore and Shanghai locations could provide a floor to valuation, yet the combination of weak earnings, high leverage and a volatile regional property market creates a high risk profile. Investors should treat the stock as a distressed value play, monitoring any debt restructuring or asset disposition news before taking a position.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI at 100 indicating overbought conditions
  • Bearish trend direction despite flat price
  • Negative earnings and high leverage

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Low price‑to‑book ratio (0.52) suggests value potential
  • Potential asset revaluation in prime locations
  • Ongoing debt burden and negative free cash flow

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Strategic property portfolio across Hong Kong, Singapore and Shanghai
  • High debt‑to‑equity ratio limiting upside
  • Absence of dividend and analyst coverage increases uncertainty

Key Metrics & Analysis

Financial Health

Revenue Growth-32.30%
Profit Margin87.23%
ROE4.16%
ROA0.49%
Debt/Equity19.93
P/B Ratio0.5
Op. Cash Flow$584.4M
Free Cash Flow$-1743887488

Technical Analysis

TrendBearish
RSI100.0
Support$7.41
Resistance$7.41
MA 20$7.41
MA 50$7.41
MA 200$7.41
MACDNeutral
VolumeStable
Fear & Greed Index91.46

Valuation

GradeUndervalued
TypeValue

Risk Assessment

00
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.